tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Autolus Therapeutics presents clinical data updates at EHA Congress
PremiumThe FlyAutolus Therapeutics presents clinical data updates at EHA Congress
2M ago
Autolus Therapeutics’ Earnings Call: AUCATZYL’s Strong Start Amid Financial Challenges
Premium
Company Announcements
Autolus Therapeutics’ Earnings Call: AUCATZYL’s Strong Start Amid Financial Challenges
2M ago
Autolus Therapeutics Reports Q1 2025 Earnings and Progress
Premium
Company Announcements
Autolus Therapeutics Reports Q1 2025 Earnings and Progress
2M ago
Autolus Therapeutics reports Q1 EPS (26c), consensus (25c)
PremiumThe FlyAutolus Therapeutics reports Q1 EPS (26c), consensus (25c)
2M ago
Autolus Therapeutics’ obecabtagene autoleucel conditionally approved by MHRA
Premium
The Fly
Autolus Therapeutics’ obecabtagene autoleucel conditionally approved by MHRA
3M ago
Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA
Premium
The Fly
Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA
3M ago
Autolus Therapeutics Announces Leadership Transition in Finance
PremiumCompany AnnouncementsAutolus Therapeutics Announces Leadership Transition in Finance
3M ago
Autolus Therapeutics price target lowered to $10 from $11 at Truist
Premium
The Fly
Autolus Therapeutics price target lowered to $10 from $11 at Truist
4M ago
Autolus Therapeutics: Positive Momentum Amid Financial Challenges
Premium
Company Announcements
Autolus Therapeutics: Positive Momentum Amid Financial Challenges
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100